AccessibilityHelp
LivaNova Plc logo

LivaNova Plc(NASDAQ) LIVN

Market Cap$4.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1993)+554%
5 Year-3%
1 Year+43%
1 Month+0%
Premium Feature
Moneyball Superscore
69/100
$81.33
+3.68%
+2.89Today
After hours$81.30-$0.03 (-0.03%)
LivaNova Plc last closing stock price
MetricPriceDate
Last closeUSD 78.442026-10-21
LivaNova Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.1%USD 76.082026-10-14
1 month+0.35%USD 78.172026-09-21
3 month-0.22%USD 78.612026-07-23
Year to date+27.48%USD 61.532025-12-31
1 year+43.37%USD 54.712025-10-21
3 year+58.75%USD 49.412023-10-20
5 year-3.15%USD 80.992021-10-22
Since inception+553.67%USD 12.001993-02-11

LivaNova Plc Financials at a Glance

Market Cap

$4.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.47B

Net Income (TTM)

$188.58M

EPS (TTM)

$3.37

P/E Ratio

23.27

Dividend

$0.00

Beta (Volatility)

0.94 (Low)

Price

$81.33

Volume

522,872.729

Open

$78.70

Previous Close

$78.44

Daily Range

$78.35 - $81.42

52-Week Range

$48.82 - $85.76

Estimated Earnings Date

Nov 4, 2026

LIVN News

SellAlert-Green.png

LivaNova Director Sells 1,650 Shares for $131,500

Jack DelaneySep 10, 2026
DLTH log

Why Duluth Holdings, LivaNova, and Boston Beer Slumped Today

Dan CaplingerApr 5, 2019
Heart

Here's Why LivaNova Plummeted Today

Brian Orelli, PhDApr 5, 2019
LB Bath and Body Works

Why L Brands, Devon Energy, and LivaNova Slumped Today

Dan CaplingerNov 20, 2018
Depression

Here's Why LivaNova Dropped Today

Brian Orelli, PhDNov 20, 2018
stock up bar chart getty

Here's Why LivaNova Rose as Much as 13% Today

Maxx ChatskoMay 31, 2018

LIVN: Motley Fool Moneyball Superscore

69

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About LivaNova Plc

LivaNova PLC NASDAQ:LIVN helps patients with heart and brain conditions. Its products support surgeons during complex heart procedures. It also treats epilepsy using nerve stimulation.

What's in the Medical Kit?

  • Cardiopulmonary Systems: Equipment for heart surgery like oxygenators and heart-lung machines; net revenue was $430.2 million for the six months ended June 30, 2026.
  • Neuromodulation Devices: Systems that stimulate the vagus nerve to treat drug-resistant epilepsy and difficult-to-treat depression; net revenue was $318.7 million for the six months ended June 30, 2026.
  • Obstructive Sleep Apnea Solutions: Neurostimulation devices designed to keep airways open during sleep by activating specific tongue muscles.
  • Advanced Circulatory Support: Technology that provides temporary life support for the heart or lungs.

Growth and New Clearances

  • Received FDA Premarket Approval for the aura6000 System to treat obstructive sleep apnea on March 18, 2026.
  • Launched the Essenz Perfusion System, a next-generation heart-lung machine with advanced patient monitoring tools.
  • Secured a favorable tax ruling in Italy in May 2026 regarding environmental liability deductions.
  • Collaborated with Verily to research clinical biomarkers for patients suffering from depression.

What Sets LivaNova Apart

LivaNova operates a global distribution network that combines direct sales teams with independent distributors. The company integrates sensing technology into its hardware to enable data-driven clinical decisions during surgeries.

Key Financial Figures

  • Net revenue reached $752.8 million for the six months ended June 30, 2026, up 12.5% year over year.
  • Net income was $130.9 million for the six months ended June 30, 2026, compared to a net loss of $300.2 million in the prior year period.
  • Market capitalization grew to $4.5 billion by the second quarter of 2026, up 84.1% year over year.
  • Research and development expense rose to $112.4 million for the six months ended June 30, 2026.
  • The price-to-earnings ratio was 10.4 in the second quarter of 2026, down 53.9% year over year.

Bottom Line

LivaNova has transitioned its focus toward high-tech neuromodulation and advanced cardiopulmonary systems. Its commitment to specialized medical technology supports its role in modern clinical environments.

AI Generated • Aug 6, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

3,300

CEO

Vladimir A. Makatsaria, MBA

Website

www.livanova.com

Headquarters

Gloucester, GL GL3 4FE, GB

LIVN Financials

Key Financial Metrics (TTM)

Gross Margin

68.18%

Operating Margin

13.48%

Net Income Margin

12.82%

Return on Equity

15.41%

Return on Capital

11.92%

Return on Assets

7.14%

Earnings Yield

4.30%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

55.09M

Volume

522.87K

Avg. Volume

648.35K

Financials (TTM)

Gross Profit

$1.00B

Operating Income

$198.30M

EBITDA

$216.54M

Operating Cash Flow

$249.26M

Capital Expenditure

-$100.92M

Free Cash Flow

$148.34M

Cash & ST Invst.

$516.62M

Total Debt

$351.95M

LivaNova Plc Performance Analysis

LivaNova Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,021,805,000-1.3%
20232023-12-31USD 1,153,545,00012.9%
20242024-12-31USD 1,253,437,0008.7%
20252025-12-31USD 1,388,053,00010.7%
LivaNova Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.5%
Q42025-12-310.9%
Q12026-03-310.4%
Q22026-06-307.8%
LivaNova Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.61-39.9%
20232023-12-31USD 0.32N/A
20242024-12-31USD 1.16258.0%
20252025-12-31USD -4.45N/A
LivaNova Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-2.0%
Q42025-12-3116.3%
Q12026-03-31-29.8%
Q22026-06-30382.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$390.60M

+10.8%

Gross Profit

$273.70M

+14.5%

Gross Margin

70.07%

N/A

Market Cap

$4.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.31M

N/A

Employees

3,300

N/A

Net Income

$108.60M

+299.8%

EBITDA

$43.90M

-27.6%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$516.62M

-13.0%

Total Debt

$351.95M

-27.1%

Accounts Receivable

$274.17M

+8.4%

Inventory

$172.61M

+4.4%

Long Term Debt

$339.58M

-13.2%

Short Term Debt

$12.37M

-86.5%

Return on Assets

7.14%

N/A

Return on Invested Capital

10.25%

N/A

Free Cash Flow

$35.04M

-26.7%

Operating Cash Flow

$66.59M

+5.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HAEHaemonetics Corporation
$116.16-0.81%
INSPInspire Medical Systems, Inc.
$72.66+2.24%
NPCENeuroPace, Inc.
$13.14+0.69%
MOBIMobia Medical, Inc. Common Stock
$10.58+9.75%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$7.87-14.92%
SPCXSpace Exploration Technologies
$144.75-9.14%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$82.11-20.47%
INTCIntel
$85.48-8.05%

Questions About LIVN

What is the current price of LivaNova Plc?

LivaNova Plc is trading at $81.27 per share.

What is the 52-week range for LivaNova Plc?

Over the past 52 weeks, LivaNova Plc has traded between $48.82 and $85.76.

How much debt does LivaNova Plc have?

As of the most recent reporting period, LivaNova Plc reported total debt of $351.95M.

How much cash does LivaNova Plc have on hand?

LivaNova Plc reported $516.62M in cash and cash equivalents in its most recent financial results.

What is LivaNova Plc’s dividend yield?

LivaNova Plc does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services